Medline Survives Tariffs, Delays on Road to Biggest US 2025 IPO
Summarize this article with:
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Medline Inc.’s long-delayed initial public offering is on track to raise the most of any listing this year, as investors keen on the medical supply company’s business model look past its rocky path back to the public markets.The company, which was taken private in 2021 by Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman in a $34 billion deal, is seeking on Tuesday to raise as much as $5.37 billion in the listing. That amount would make it the year’s biggest US IPO at the bottom of the price range, and at the top, the largest this year globally.